1 December 2024 false No description of principal activity Taxfiler 2024.6 11704644 business:PrivateLimitedCompanyLtd 2024-12-01 2025-11-30 11704644 2024-11-30 11704644 2024-12-01 2025-11-30 11704644 business:AuditExempt-NoAccountantsReport 2024-12-01 2025-11-30 11704644 business:FilletedAccounts 2024-12-01 2025-11-30 11704644 2025-11-30 11704644 business:Director1 2024-12-01 2025-11-30 11704644 business:RegisteredOffice 2024-12-01 2025-11-30 11704644 2024-11-30 11704644 core:WithinOneYear 2025-11-30 11704644 core:WithinOneYear 2024-11-30 11704644 core:ShareCapital core:PreviouslyStatedAmount 2025-11-30 11704644 core:ShareCapital core:PreviouslyStatedAmount 2024-11-30 11704644 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2025-11-30 11704644 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2024-11-30 11704644 core:PreviouslyStatedAmount 2025-11-30 11704644 core:PreviouslyStatedAmount 2024-11-30 11704644 business:SmallEntities 2024-12-01 2025-11-30 11704644 countries:EnglandWales 2024-12-01 2025-11-30 11704644 core:FurnitureFittings 2024-12-01 2025-11-30 11704644 core:FurnitureFittings 2024-11-30 11704644 core:FurnitureFittings 2025-11-30 11704644 2023-12-01 2024-11-30 iso4217:GBP xbrli:pure
Company Registration No. 11704644 (England and Wales)
Ishaq Pharma Ltd Unaudited accounts for the year ended 30 November 2025
Ishaq Pharma Ltd Unaudited accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
Ishaq Pharma Ltd Company Information for the year ended 30 November 2025
Director
Shahbaz Ishaq
Company Number
11704644 (England and Wales)
Registered Office
17 Heaton Park Drive Bradford West Yorkshire BD9 5QH England
Accountants
Taj Javed Ltd Chartered Certified Accountants 28 Haslingden Drive, Heaton Bradford West Yorkshire BD9 5HR
- 3 -
Ishaq Pharma Ltd Statement of financial position as at 30 November 2025
2025
2024
Notes
£
£
Fixed assets
Tangible assets
4
544
664
Current assets
Debtors
5
4,958
5,931
Cash at bank and in hand
130,230
95,742
135,188
101,673
Creditors: amounts falling due within one year
6
(77,350)
(57,933)
Net current assets
57,838
43,740
Net assets
58,382
44,404
Capital and reserves
Called up share capital
1
1
Profit and loss account
58,381
44,403
Shareholders' funds
58,382
44,404
For the year ending 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 12 August 2026 and were signed on its behalf by
Shahbaz Ishaq Director Company Registration No. 11704644
- 4 -
Ishaq Pharma Ltd Notes to the Accounts for the year ended 30 November 2025
1
Statutory information
Ishaq Pharma Ltd is a private company, limited by shares, registered in England and Wales, registration number 11704644. The registered office is 17 Heaton Park Drive, Bradford, West Yorkshire, BD9 5QH, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Fixtures & fittings
18% Reducing balance basis
4
Tangible fixed assets
Fixtures & fittings
£
Cost or valuation
At cost
At 1 December 2024
1,274
At 30 November 2025
1,274
Depreciation
At 1 December 2024
610
Charge for the year
120
At 30 November 2025
730
Net book value
At 30 November 2025
544
At 30 November 2024
664
5
Debtors
2025
2024
£
£
Amounts falling due within one year
Accrued income and prepayments
4,958
5,914
Other debtors
-
17
4,958
5,931
- 5 -
Ishaq Pharma Ltd Notes to the Accounts for the year ended 30 November 2025
6
Creditors: amounts falling due within one year
2025
2024
£
£
Taxes and social security
5,888
5,820
Loans from directors
69,612
51,213
Accruals
1,850
900
77,350
57,933
7
Average number of employees
During the year the average number of employees was 2 (2024: 2).
- 6 -